<?xml version="1.0" encoding="UTF-8"?>
<p>Not only is it considered an effective vaccine, but data suggests that a single dose of YF vaccine may confer life-long protection against YF disease [
 <xref rid="B117-vaccines-07-00179" ref-type="bibr">117</xref>,
 <xref rid="B118-vaccines-07-00179" ref-type="bibr">118</xref>]. In 2013, the WHO Strategic Advisory Group of Experts (SAGE) working group for YF vaccination recommended that the 2003 WHO position on 17D booster schedules and international health regulations be revised to remove the 10-year booster dose requirement [
 <xref rid="B118-vaccines-07-00179" ref-type="bibr">118</xref>]. In 2015, the Advisory Committee on Immunization Practices (ACIP) issued similar guidance on the adequacy of a single dose of YF vaccine for most travelers. However, ACIP also recommended that at-risk laboratory personnel and certain travelers receive additional doses of YF vaccine [
 <xref rid="B76-vaccines-07-00179" ref-type="bibr">76</xref>]. Additionally, the impact of no booster vaccination is being investigated among children as there is little evidence to support long-term persistence of protective immunity in primary vaccinated children [
 <xref rid="B119-vaccines-07-00179" ref-type="bibr">119</xref>].
</p>
